FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019041562> ?p ?o ?g. }

• W2019041562 endingPage "169" @default.
• W2019041562 startingPage "162" @default.
• W2019041562 abstract "We compared the efficacy and the safety of a carboplatin plus etoposide regimen (CE) vs split doses of cisplatin plus etoposide (SPE) in elderly or poor-risk patients with extensive disease small-cell lung cancer (ED-SCLC). Eligibility criteria included: untreated ED-SCLC; age ⩾70 and performance status 0–2, or age <70 and PS 3. The CE arm received carboplatin area under the curve of five intravenously (IV) on day 1 and etoposide 80 mg m−2 IV on days 1–3. The SPE arm received cisplatin 25 mg m−2 IV on days 1–3 and etoposide 80 mg m−2 IV on days 1–3. Both regimens were given with granulocyte colony-stimulating factor support in a 21–28 day cycle for four courses. A total of 220 patients were randomised. Median age was 74 years and 74% had a PS of 0 or 1. Major grade 3–4 toxicities were (%CE/%SPE): leucopenia 54/51, neutropenia 95/90, thrombocytopenia 56/16, infection 7/6. There was no significant difference (CE/SPE) in the response rate (73/73%) and overall survival (median 10.6/9.9 mo; P=0.54). Palliation scores were very similar between the arms. Although the SPE regimen is still considered to be the standard treatment in elderly or poor-risk patients with ED-SCLC, the CE regimen can be an alternative for this population considering the risk–benefit balance." @default.
• W2019041562 created "2016-06-24" @default.
• W2019041562 creator A5005125682 @default.
• W2019041562 creator A5045329864 @default.
• W2019041562 creator A5050855780 @default.
• W2019041562 creator A5051530510 @default.
• W2019041562 creator A5052605297 @default.
• W2019041562 creator A5058549884 @default.
• W2019041562 creator A5065387771 @default.
• W2019041562 creator A5074857320 @default.
• W2019041562 creator A5082354025 @default.
• W2019041562 creator A5086351004 @default.
• W2019041562 date "2007-06-19" @default.
• W2019041562 modified "2023-10-17" @default.
• W2019041562 title "Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702" @default.
• W2019041562 cites W1794914953 @default.
• W2019041562 cites W1851872955 @default.
• W2019041562 cites W1907795058 @default.
• W2019041562 cites W1912196342 @default.
• W2019041562 cites W1968483728 @default.
• W2019041562 cites W1970029232 @default.
• W2019041562 cites W1995323461 @default.
• W2019041562 cites W2013123615 @default.
• W2019041562 cites W2015403436 @default.
• W2019041562 cites W2039123736 @default.
• W2019041562 cites W2039744397 @default.
• W2019041562 cites W2045521598 @default.
• W2019041562 cites W2045949627 @default.
• W2019041562 cites W2060499368 @default.
• W2019041562 cites W2062668422 @default.
• W2019041562 cites W2064003771 @default.
• W2019041562 cites W2067965045 @default.
• W2019041562 cites W2073683299 @default.
• W2019041562 cites W2110182487 @default.
• W2019041562 cites W2122658272 @default.
• W2019041562 cites W2142195688 @default.
• W2019041562 cites W2146589818 @default.
• W2019041562 cites W2151177054 @default.
• W2019041562 cites W2151518427 @default.
• W2019041562 cites W2156836360 @default.
• W2019041562 cites W2180933151 @default.
• W2019041562 cites W2206037823 @default.
• W2019041562 cites W2440995134 @default.
• W2019041562 cites W3144710052 @default.
• W2019041562 cites W4240968251 @default.
• W2019041562 doi "https://doi.org/10.1038/sj.bjc.6603810" @default.
• W2019041562 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2360311" @default.
• W2019041562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17579629" @default.
• W2019041562 hasPublicationYear "2007" @default.
• W2019041562 type Work @default.
• W2019041562 sameAs 2019041562 @default.
• W2019041562 citedByCount "170" @default.
• W2019041562 countsByYear W20190415622012 @default.
• W2019041562 countsByYear W20190415622013 @default.
• W2019041562 countsByYear W20190415622014 @default.
• W2019041562 countsByYear W20190415622015 @default.
• W2019041562 countsByYear W20190415622016 @default.
• W2019041562 countsByYear W20190415622017 @default.
• W2019041562 countsByYear W20190415622018 @default.
• W2019041562 countsByYear W20190415622019 @default.
• W2019041562 countsByYear W20190415622020 @default.
• W2019041562 countsByYear W20190415622021 @default.
• W2019041562 countsByYear W20190415622022 @default.
• W2019041562 countsByYear W20190415622023 @default.
• W2019041562 crossrefType "journal-article" @default.
• W2019041562 hasAuthorship W2019041562A5005125682 @default.
• W2019041562 hasAuthorship W2019041562A5045329864 @default.
• W2019041562 hasAuthorship W2019041562A5050855780 @default.
• W2019041562 hasAuthorship W2019041562A5051530510 @default.
• W2019041562 hasAuthorship W2019041562A5052605297 @default.
• W2019041562 hasAuthorship W2019041562A5058549884 @default.
• W2019041562 hasAuthorship W2019041562A5065387771 @default.
• W2019041562 hasAuthorship W2019041562A5074857320 @default.
• W2019041562 hasAuthorship W2019041562A5082354025 @default.
• W2019041562 hasAuthorship W2019041562A5086351004 @default.
• W2019041562 hasBestOaLocation W20190415621 @default.
• W2019041562 hasConcept C126322002 @default.
• W2019041562 hasConcept C141071460 @default.
• W2019041562 hasConcept C2776256026 @default.
• W2019041562 hasConcept C2776694085 @default.
• W2019041562 hasConcept C2777063308 @default.
• W2019041562 hasConcept C2778119113 @default.
• W2019041562 hasConcept C2778239845 @default.
• W2019041562 hasConcept C2781413609 @default.
• W2019041562 hasConcept C2781451048 @default.
• W2019041562 hasConcept C2908647359 @default.
• W2019041562 hasConcept C71924100 @default.
• W2019041562 hasConcept C90924648 @default.
• W2019041562 hasConcept C99454951 @default.
• W2019041562 hasConceptScore W2019041562C126322002 @default.
• W2019041562 hasConceptScore W2019041562C141071460 @default.
• W2019041562 hasConceptScore W2019041562C2776256026 @default.
• W2019041562 hasConceptScore W2019041562C2776694085 @default.
• W2019041562 hasConceptScore W2019041562C2777063308 @default.
• W2019041562 hasConceptScore W2019041562C2778119113 @default.
• W2019041562 hasConceptScore W2019041562C2778239845 @default.
• W2019041562 hasConceptScore W2019041562C2781413609 @default.
• W2019041562 hasConceptScore W2019041562C2781451048 @default.

• next